The biosynthesis and metabolism of dopaminergic drugs, dopamine agonists, monoamine oxidase B inhibitors, catechol-O-methyl transferase inhibitors, anticholinergics, and amantadine used in the management of PD are established and well understood [8]. The gene discussed is MAOB; the disease is Parkinson disease.